Dr. Blobe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
20 Duke Medicine Circle
Durham, NC 27710Phone+1 919-668-6688
Education & Training
- Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 1997 - 2000
- Brigham and Women's HospitalResidency, Internal Medicine, 1995 - 1997
- Duke University School of MedicineClass of 1995
Certifications & Licensure
- NC State Medical License 2000 - 2025
- FL State Medical License 2018 - 2020
- MA State Medical License 1997 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2019
- America's Top Doctors for Cancer Castle Connolly, 2011-2019
- Elected Member The American Society for Clinical Investigation, 2008
Clinical Trials
- QUILT-3.019: Phase 2 Study of NPC-1C Chimeric Monoclonal Antibody to Treat Pancreatic and Colorectal Cancer Start of enrollment: 2012 Jan 01
- Studying Gene Expression in Samples From Younger Patients With Neuroblastoma Start of enrollment: 2012 Mar 01
Publications & Presentations
PubMed
- 505 citationsRole of Transforming Growth Factor Beta in Human CancerRebecca L. Elliott, Gerard C. Blobe
Journal of Clinical Oncology. 2005-03-20 - 67 citationsTGF-β-induced stromal CYR61 promotes resistance to gemcitabine in pancreatic ductal adenocarcinoma through downregulation of the nucleoside transporters hENT1 and hCNT3Rachel A. Hesler, Jennifer J. Huang, Mark D. Starr, Victoria M. Treboschi, Alyssa G. Bernanke
Carcinogenesis. 2016-11-01 - 1949 citationsRole of transforming growth factor beta in human disease.Gerard C. Blobe, William P. Schiemann, Harvey F. Lodish
The New England Journal of Medicine. 2000-05-04
Press Mentions
- Dr. Gerard Blobe, M.D., Ph.D., Joins Vivacitas Oncology's Solid Tumor Medical Advisory BoardMarch 7th, 2022
- Recipients of AACR Research Funding & Fellowships 1993–2017September 8th, 2017
Grant Support
- Role Of Tbriii In Regulating Motility And InvasionNational Cancer Institute2009–2011
- Function Of Tbriii As A BMP Co-Receptor In Human CancerNational Cancer Institute2009–2011
- Multispectral Imaging Flow Cytometer CoreNational Center For Research Resources2010
- Tbetariii As A Mediator/Regulator Of SignalingNational Cancer Institute2005–2009
- ALK-1 And Endoglin Signaling In Endothelial CellsNational Cancer Institute2004–2008
- Role Of The Type III Tgf-Beta Receptor In Cancer BiologyNational Cancer Institute2004–2007
- Type III Tgf-Beta Receptor In Tgf-Beta SignalingNational Cancer Institute2002–2004
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: